Literature DB >> 15877284

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese.

Hekun Liu1, Sizhong Zhang, Jianyin Lin, Hai Li, Aimin Huang, Cuiying Xiao, Xuefei Li, Zhiguang Su, Chunting Wang, Daniel W Nebert, Bing Zhou, Keqin Zheng, Jiajun Shi, Guixin Li, Dejia Huang.   

Abstract

The recently discovered apolipoprotein A5 ( APOA5 ) gene has been shown to be important in determining plasma triglyceride levels, a major cardiovascular disease risk factor. We searched for possible associations of the APOA5 gene polymorphisms S19W and -1131T>C with coronary heart disease (CHD) in a Chinese population. A total of 483 Chinese CHD patients and 502 control non-CHD subjects were genotyped by polymerase chain reaction-restriction fragment length polymorphism for these 2 single nucleotide polymorphisms. We found that the minor allele 19W was observed only in CHD patients and not in controls, with allelic frequencies of 0.047 and 0.000, respectively ( P < .000001), and the minor allele -1131C was significantly higher in CHD patients than in controls (0.391 vs 0.299, P < .0001). These results suggest that both the S19W and -1131T>C variations in the APOA5 gene are associated with the CHD and appear to be 2 genetic risk factors for CHD susceptibility in Chinese. Moreover, we found that triglyceride levels were significantly higher in -1131C carriers than in -1131T subjects of the control group and that high-density-lipoprotein cholesterol was decreased in -1131C carriers among CHD patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877284     DOI: 10.1016/j.metabol.2004.11.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  19 in total

1.  APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.

Authors:  Dolores Corella; Chao-Qiang Lai; Serkalem Demissie; L Adrienne Cupples; Alisa K Manning; Katherine L Tucker; Jose M Ordovas
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

2.  A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese.

Authors:  Chao Qiang Jiang; Bin Liu; Bernard M Y Cheung; Tai Hing Lam; Jie Ming Lin; Ya Li Jin; Xiao Jun Yue; Kwok Leung Ong; Sidney Tam; Ka Sing Wong; Brian Tomlinson; Karen S L Lam; G Neil Thomas
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

3.  -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Authors:  Mirelle O Sóter; Karina B Gomes; Ana P Fernandes; Maria das G Carvalho; Poliana S Pinheiro; Adriana A Bosco; Daniel D R Silva; Marinez O Sousa
Journal:  Mol Biol Rep       Date:  2012-02-19       Impact factor: 2.316

4.  Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.

Authors:  Tongfeng Zhao; Jiangpei Zhao
Journal:  BMC Med Genet       Date:  2010-08-10       Impact factor: 2.103

5.  Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke.

Authors:  Anita Maász; Péter Kisfali; Zoltán Szolnoki; Ferenc Hadarits; Béla Melegh
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

Review 6.  Apoprotein A-V: an important regulator of triglyceride metabolism.

Authors:  M Kluger; J Heeren; M Merkel
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

7.  Association of APOA5 T1131C polymorphism and risk of coronary artery disease.

Authors:  Jing Xia; Weiping Cai; Caosheng Peng
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.

Authors:  Yan-Yan Li; Xiao-Yan Wu; Jian Xu; Yun Qian; Chuan-Wei Zhou; Bei Wang
Journal:  Mol Biol Rep       Date:  2012-11-06       Impact factor: 2.316

9.  Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Wan-Ying Liu; Lin Zhang; Jin-Zhen Wu
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

10.  Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis.

Authors:  Chunxiao Xu; Rongpan Bai; Dandan Zhang; Zhenli Li; Honghong Zhu; Maode Lai; Yimin Zhu
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.